News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Universities Ramping Up Efforts to Discover Drugs


10/22/2013 8:47:57 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Merck ’s recent announcement about dramatically cutting R&D is just the latest such move in the pharmaceutical industry. Merck joins a number of companies including Pfizer , Lilly, AstraZeneca , etc., who have reasoned that decreasing sales due to patent expirations necessitates “right sizing” its internal R&D operations. All of these companies have sought to lower costs through greater efficiencies and slimming down R&D programs. However, to meet the budget goals, far more drastic cuts are needed and so companies are eliminating a good deal of their “bricks & mortar” – the R&D labs. The labs where iconic drugs such as Singulair, Lipitor, Viagra and Celebrex no longer exist as they have fallen to the budget axe.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes


comments powered by Disqus
Forbes
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES